Seeking a Prescription for Biogenerics No U.S. laws allow for generic versions of off-patent biotech medicines. Several forces are now […]

Why Merck Missed the Mark S&P’s Herman Saftlas talks about the Street’s reaction to the drug giant’s disappointing earnings report

Biotech: Teva’s Next Triumph? The Israeli maker of generics wants a piece of the fast-growing bio-drug market

Biotech: Teva’s Next Triumph? The Israeli maker of generics wants a piece of the fast-growing bio-drug market

Gene Therapy Rebuilds Gums Gene therapy can restore damage caused by severe gum disease, suggest animal studies.

Is Viagra Vulnerable? Eli Lilly’s Cialis lasts for 36 hours–and a $100 million ad blitz will spread the word

It’s Wake-Up Time Kiss your pillow good-bye. A new breed of drugs promises to do for drowsiness what Prozac did

It’s Wake-Up Time Kiss your pillow good-bye. A new breed of drugs promises to do for drowsiness what Prozac did

Biotech plans: Boon or fantasy? Having mapped hormones, synthesized molecules and discovered new cell receptors, the Scripps Research Institute wants

REDISCOVERING NATURAL PRODUCTS Cast aside for years, natural products drug discovery appears to be reclaiming attention and on the verge